Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ProMetic Life Sciences Company Profile (TSE:PLI)

Consensus Ratings for ProMetic Life Sciences (TSE:PLI) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: C$2.58

Analysts' Ratings History for ProMetic Life Sciences (TSE:PLI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/20/2014Paradigm CapitalBoost Price TargetBuyC$2.80 -> C$2.90ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014Panmure GordonInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/11/2014Canaccord GenuityBoost Price TargetBuyC$2.00 -> C$2.25ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Paradigm CapitalBoost Price TargetBuyC$2.25 -> C$2.80ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Canaccord GenuityInitiated CoverageBuyC$2.00ViewTweet This Rating  Share This Rating on StockTwits
1/23/2014Paradigm CapitalBoost Price TargetBuyC$1.35 -> C$2.25ViewTweet This Rating  Share This Rating on StockTwits
10/17/2013Paradigm CapitalBoost Price TargetC$0.90 -> C$1.35ViewTweet This Rating  Share This Rating on StockTwits
9/12/2013Paradigm CapitalBoost Price TargetBuyC$0.85 -> C$0.90ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/1/2012 forward)
Discuss ProMetic Life Sciences